Affiliation:
1. Peoples’ Friendship University of Russia
2. City Clinical Hospital № 24 of Moscow
Abstract
This article describes the clinical case of acute gangrenous appendicitis in a pregnant woman, followed by antibiotic therapy with meropenem dose of 2 g I. V. q8h with therapeutic drug monitoring (TDM) management. Therapeutic drug monitoring may be helpful for special patient populations with large pharmacokinetic variability, which include pregnant women. The goal of therapeutic drug monitoring is to increase the effectiveness of therapy by adjusting the dose and dosage regimen, as well as reducing the likelihood of side effects.
Publisher
PANORAMA Publishing House
Subject
General Chemical Engineering
Reference33 articles.
1. Basalingappa, S., Sharma, A., Amarnath, S. 2015. Basic concepts of therapeutic drug monitoring. International Journal of Current Pharmaceutical Review and Research. 5. 70–75.
2. Kang J. S., Lee M. H. Overview of therapeutic drug monitoring. Korean J Intern Med. 2009 Mar;24 (1):1–10. doi: 10.3904/kjim.2009.24.1.1. PMID: 19270474; PMCID: PMC2687654.
3. Sokolov, A. V. Terapevticheskij lekarstvennyj monitoring [Therapeutic medicinal monitoring]. Good Clinical Practices. 2002; 1: 6–11.
4. Costantine, M. M. Physiologic and pharmacokinetic changes in pregnancy. Front Pharmacol. 2014. Apr 3;5:65. doi: 10.3389/fphar.2014.00065. PMID: 24772083; PMCID: PMC3982119.
5. Anger, G. J., Costantine, M. M., Piquette-Miller, M. 2011. Pharmacokinetics in pregnancy. Reproductive and Developmental Toxicology, 39–45. doi:10.1016/b978-0-12-382032-7.10004–9